AGC Biologics, Quell Therapeutics partner to advance Treg cell therapies
Under the partnership, AGC Biologics will supply lentiviral vector (LVV) material through its ProntoLVV platform and Quell its expertise in advanced treatments for immune and inflammatory disorders
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry